Financial Performance & Guidance - The company projects FY2025 revenue between $825 million and $835 million[7] - The company anticipates FY2025 net income between $56 million and $60 million[7] - The company expects FY2025 adjusted EBITDA between $124 million and $128 million[7] - The company is targeting an average annual revenue growth of approximately 10% through FY29, with an adjusted EBITDA margin approaching 20% by FY29[7] Strategic Initiatives - The company is implementing a "North Star Strategy" to accelerate growth, diversification, and optimization[45] - The company plans to launch a minimum of six new programs annually at existing campuses starting in FY2025[45] - The company intends to open at least two new campuses each year between FY2026 and FY2029[45] Division Performance (FY2024) - The UTI Division generated $486 million in revenue with approximately 14,000 average students[12] - The Concorde Division generated $246 million in revenue with approximately 8,000 average students[12]

Financial Performance - GAAP Gross Profit for the three months ended March 31, 2025 was $79508 thousand, resulting in a GAAP Gross Margin of 695%[42] - Non-GAAP Gross Profit for the three months ended March 31, 2025 was $82613 thousand, yielding a Non-GAAP Gross Margin of 722%[42] - Adjusted EBITDA for the three months ended March 31, 2025, reached $24715 thousand, representing 216% of revenue[47] - GAAP Net Income for the three months ended March 31, 2025, was $7047 thousand, or 62% of revenue[47] - Non-GAAP Net Income for the three months ended March 31, 2025, amounted to $24476 thousand[55] Strategic Initiatives and Product Development - Prosigna LDT is expected to be commercially available in mid-2026[19] - The company submitted a tech assessment to MolDx for MIBC in March 2025, with commercial launch and reimbursement expected in the first half of 2026[22] - NIGHTINGALE pivotal trial enrollment is approximately 95% complete, with completion expected in Q3[28] Operational Expenses - Non-GAAP research and development expenses for the three months ended March 31, 2025, were $15654 thousand[44] - Non-GAAP sales and marketing expenses for the three months ended March 31, 2025, totaled $22496 thousand[44] - Non-GAAP general and administrative expenses for the three months ended March 31, 2025, were $22348 thousand[44]

Financial Performance - Net sales reached $38 million[10], a 2% increase compared to the previous year[10] - Gross margin improved to 50.1%[10], a 440 basis points increase compared to the previous year[10] - Net loss was -$6.4 million[10], an improvement of $0.8 million compared to the previous year[10] - Adjusted EBITDA loss was -$3.3 million[10], an improvement of $2.2 million compared to the previous year[10] Strategic Growth Pillars - The company focuses on amplifying marketing[11], driving product innovation[11], expanding distribution[11], and delivering profitability[11] Marketing Impact - The "Get the Fake Outta Here" campaign generated 2.4 billion positive consumer press impressions[12] - The campaign resulted in the most engagements ever on Zevia social media[12]

First Quarter 2025 Earnings Presentation May 7, 2025 © 2025 LIGHT & WONDER Forward-Looking Statements SECTION TITLE, 10PT In this presentation, Light & Wonder makes "forward-looking statements" within the meaning of the U.S. Private Securities Litigation Reform Act of 1995. Forward-looking statements describe future expectations, plans, results or strategies and can often be identified by the use of terminology such as "may," "will," "estimate," "intend," "plan," "continue," "believe," "expect," "anticipate ...

May 7, 2025 Safe harbor & forward looking statements This communication contains forward-looking statements related to Sunrun (the "Company") within the meaning of Section 27A of the Securities Act of 1933, and Section 21E of the Securities Exchange Act of 1934 and the Private Securities Litigation Reform Act of 1995. Such forward-looking statements include, but are not limited to, statements related to: the Company's financial and operating guidance and expectations; the Company's business plan, trajectory ...

Financial Performance - Net income attributable to common shareholders was $3085 thousand, a significant increase compared to a net loss of $26341 thousand in the year-ago period[10] - Operating FFO was $8282 thousand, down from $59801 thousand in the previous year[10] - The company recorded $8400 thousand in other property revenues related to a condemnation proceeding in Florida[10] Portfolio Operations - The leased rate was 89.8% as of March 31, 2025, compared to 91.7% at March 31, 2024[10] - The commenced rate was 89.4% at the end of the quarter, slightly down from 89.8% year-over-year[10] - The company executed 5 new leases and 17 renewals, totaling 75000 square feet during the quarter[10] - Cash renewal leasing spreads were 3.4% for the first quarter of 2025[10] Asset Sales and Strategy - SITE Centers has two properties under contract for sale with an aggregate price of $95300 thousand[6] - Additional properties are in various stages of contract negotiations or marketing, exceeding $350000 thousand[6] Capital Structure - The market value per share was $12.84 as of March 31, 2025, compared to $15.29 at the end of 2024[30] - Common shares equity totaled $673394 thousand[30] - Net debt was $332013 thousand[30]

Q1 2025 Financial Performance - Total revenue reached $82.3 million, a 5.5% increase year-over-year [4] - Total constant currency revenue was also $82.3 million, representing a 7.1% increase [4] - Net loss was $(6.174) million, an improvement compared to $(14.578) million in the same period last year [5] - Adjusted EBITDA (non-GAAP) was $36 thousand, a significant increase from $(7.642) million in the prior year [7] - Adjusted net loss was $(2.888) million, compared to $(10.422) million in the prior year [9] Revenue Breakdown by Category - Business-to-business domestic sales contributed $21.5 million, a 29.9% increase, representing 26.1% of total revenue [4] - Business-to-business international sales amounted to $32.0 million, a 22.9% increase, accounting for 38.9% of total revenue [4] - Direct-to-consumer domestic sales were $15.0 million, a decrease of 26.8%, making up 18.2% of total revenue [4] - Rental revenue was $13.8 million, a decrease of 7.5%, representing 16.8% of total revenue [4] Operating Expenses - Total operating expenses were $44.028 million, a decrease from $50.645 million in the prior year [5] - Research and development expenses decreased to $4.034 million from $6.578 million [5] - Sales and marketing expenses decreased to $23.757 million from $26.936 million [5] - General and administrative expenses decreased to $16.237 million from $17.131 million [5]

Q1 2025 Earnings May 7, 2025 Safe Harbor This presentation contains "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. All statements contained in this presentation that do not relate to matters of historical fact should be considered forward-looking statements, including, without limitation, statements regarding: expectations regarding our future results of operations and financial position, margin expansion and overall growth, including, without limita ...

Investor Presentation May 2025 © 2025 ON24, Inc. | Confidential Legal Disclaimer This presentation contains "forward-looking statements" under applicable securities laws. Such statements can be identified by words such as: "outlook," "expect," "convert," "believe," "plan," "future," "may," "should," "will," and similar references to future periods. Forward-looking statements include express or implied statements regarding our expected financial and operating results, the execution of our capital return prog ...

Corporate Presentation May 2025 Highly Purified Peptide/Protein Proprietary Injectables Inhalation Intranasal Biosimilar Interchangeable Complex Generic Combination Products Forward Looking Statements This presentation and the accompanying oral presentation contain forward-looking statements, of Amphastar Pharmaceuticals, Inc. ("Amphastar", "we". "our" and that are based on our management's current expectations and assumptions and on information currently available to management. Forward-looking statements ...